D. Jeffrey Keyser - 24 Jul 2024 Form 4 Insider Report for Lantern Pharma Inc. (LTRN)

Role
Director
Signature
/s/ Donald Jeffrey Keyser
Issuer symbol
LTRN
Transactions as of
24 Jul 2024
Net transactions value
+$11,994
Form type
4
Filing time
26 Jul 2024, 16:15:16 UTC
Previous filing
17 Jul 2024
Next filing
23 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LTRN Common stock Exercise of in-the-money or at-the-money derivative security $11,994 +3,832 $3.13 0 24 Jul 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LTRN Series A Warrants Exercise of in-the-money or at-the-money derivative security $0 -3,832 -100% $0.000000* 0 24 Jul 2024 Common Stock 3,832 $3.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 24, 2024, the Reporting Person exercised a Series A Warrant to purchase 3,832 shares of common stock at an exercise price of $3.13 per share.